Key Financial Data Of Reporting Company

Delta-Fly Pharma, Inc. - Filing #7574302

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-12-31
2021-10-01 to
2021-12-31
2021-04-01 to
2021-12-31
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-1,035,896,000 JPY
-964,064,000 JPY
-835,111,000 JPY
Profit (loss)
-1,038,299,000 JPY
-967,302,000 JPY
-837,528,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
3,629,059,000 JPY
3,352,327,000 JPY
3,352,327,000 JPY
Total number of issued shares
6,054,700 xbrli:shares
5,419,600 xbrli:shares
5,419,600 xbrli:shares
Net assets
750,728,000 JPY
1,233,161,000 JPY
1,362,935,000 JPY
Total assets
952,899,000 JPY
1,324,352,000 JPY
1,441,458,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-190.18
-75.04
-178.58
-51.68
-154.65
Diluted earnings per share
Equity-to-asset ratio
0.784 xbrli:pure
0.931 xbrli:pure
0.945 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.